FDA WARNING_LETTER - CalmCo LLC previously named Ketomi LLC - May 25, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On August 9, 2023, the FDA issued a Warning Letter to Keith Page regarding "Colic Calm" and "Colic Calm +" products, sold via www.coliccalm.com. The FDA reviewed the website in May 2023 and determined these products are unapproved new drugs under section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Introducing or delivering these products into interstate commerce violates sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. 331(d) and 355(a).
The products are considered drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), due to claims on labels and the website indicating intended use for diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect body structure/function. Examples include "Symptomatic relief of infant Colic, Gas & Reflux" and "Temporarily relieves the symptoms of infant: colic · gas · reflux · upset stomach · bloating · hiccups." "Colic Calm +" is marketed for "professional strength" and "additional gas absorption properties."
These products are not generally recognized as safe and effective (
ID · bd3db429-049b-4fe5-8706-53ba742df48b
Full citation text and observation details available on the Dashboard.